Press ReleasesCannaray Subsidiary Therismos Signs Partnership With Alliance Healthcare Deutschland, GEHE...

Cannaray Subsidiary Therismos Signs Partnership With Alliance Healthcare Deutschland, GEHE Pharma Handel, & Thier Cooperation Partners

-

THE cooperation family of Alphega and gesund leben is pleased to announce a strong partnership with their newest member, Therismos GmbH, the German subsidiary of Cannaray Ltd. Both pharmacy networks benefit equally from this innovative partnership, thus expanding their existing base of partnerships and being able to provide optimal patient care in the medical cannabis sector nationwide.

As a leading European cannabis company that includes both medical cannabis and CBD wellness brands, Therismos GmbH – the German subsidiary of Cannaray Ltd. – will supply high-quality medical cannabis products, which can now be obtained from all pharmacies in Germany via AHD and GEHE. The partnership also benefits the two pharmacy cooperations Alphega and gesund leben, with the deal including attractive purchasing conditions and discounts. Member pharmacies of both networks will also be able to complete a training program to provide patients with superior medical cannabis support, positioning themselves as local experts in the field.

“With Therismos GmbH, we now have a specialist at our side with whom our pharmacy partners can position themselves as experts in the field of medical cannabis for the benefit of their patients”, said Aline Seifert, CEO of Alliance Healthcare Deutschland and Managing Director of GEHE Pharma Handel about the latest partnership. Matthias Greutter, Country Manager Cooperation, adds: “We are very pleased that with Therismos GmbH, we have been able to win a unique partner for our cooperation family Alphega and gesund leben.”

Christian Naumann, Managing Director of Therismos GmbH, says: “We are also pleased to announce this progressive partnership with Alliance Healthcare Deutschland and GEHE Pharma Handel and their more than 4,000 cooperation partners in the ‘Alphega’ and ‘gesund leben’ network and to provide our established medical cannabis products in Germany. As a specialist in this rapidly growing sector, the pharmacy partners can already benefit from our product range today, while we are setting up the education programme in the coming weeks.”

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you